Understanding Alzheimer’s disease plaques in brain easier with amyloid protein cues

Written by Devon Andre
Published on

Understanding Alzheimer’s diseas...

Alzheimer’s plaques are clumps of fibrous protein, referred to as amyloid plaques, commonly found in the brains of Alzheimer’s patients. Amyloid plaques were first discussed about 150 years ago and have since been associated with Parkinson’s disease, Huntington’s disease, rheumatoid arthritis and Alzheimer’s disease. Recent findings suggest that amyloid plaques may also have a beneficial role in the function of healthy cells.

MIT biologists found that yeast cells need to build amyloid-like structures during the production of reproductive cells. Lead author, Luke Berchowitz, said, “Amyloids in the brain persist for decades. We just can’t get rid of them, yet yeast cells seem to have a mechanism for getting rid of them in 15 minutes. If we can harness that mechanism, and really understand it, that could lead to anti-amyloid therapeutic opportunities.”

While exploring sexual reproduction the researchers found amyloid-forming protein known as RIM4. RIM4 has previously been shown to latch onto RNA molecules which carry genetic information. The new study found RIM4 uses amyloid-like clusters to prevent RNA from being transcribed into proteins.

Learning more about amyloid-forming proteins, and how they break down and lead to disease, can help scientist create more effective treatments and potential cures.

Berchowitz concluded, “It’s a great opportunity to study assembly, regulation, and function of amyloids in living cells. It’s pretty exciting that we can form them rapidly, synchronously, and abundantly.”

The findings were published in Cell.



On any matter relating to your health or well-being, please check with an appropriate health professional. No statement herein is to be construed as a diagnosis, treatment, preventative, or cure for any disease, disorder or abnormal physical state. The statements herein have not been evaluated by the Foods and Drugs Administration or Health Canada. Dr. Marchione and the doctors on the Bel Marra Health Editorial Team are compensated by Bel Marra Health for their work in creating content, consulting along with formulating and endorsing products.